BafnaPharmaceuticals BAFNAPH full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• IntraDay predictions, targets, What to do BAFNAPH
• Forcast & Targets BAFNAPH
• BAFNAPH Experts view
• Tomorrow's Movement BAFNAPH
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• BAFNAPH History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of BafnaPharmaceuticals

Tomorrow's movement Prediction of Bafna Pharmaceuticals BAFNAPH appears to be in uptrend. But this trend seems to be weakening.

Price is above an important level of 113.38 on charts, and as long as price remains above this level, the uptrend of stock might continue.

Tomorrow's movement Prediction of Bafna Pharmaceuticals BAFNAPH made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Tomorrow's movement Prediction of Bafna Pharmaceuticals BAFNAPH appears strongly Bearish. This stock started falling as soon as it opened and never recovered during the session. Generally this happens when there is a negative sentiment following the stock, making it unattractive. There's a good chance that this downfall will continue tomorrow as well. However, if it manages to close higher than where it opened today, then there might be a chance of reversal.

Munafa value: 40 as on Tue 24 March 2026

This Munafa value indicates that the stock is moving downwards and might continue to move down.

SMA20 is at 110 and price is deviating by 7 points

Upper Bollinger band is at 123 and lower is at 98, while middle bands are at 104 and 117

Price is coming down

Price is above 20day SMA

Price is in lower range of bands

Price action analysis of BafnaPharmaceuticals (BAFNAPH) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for BafnaPharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for BafnaPharmaceuticals in short term and the buy signal is strong.

BafnaPharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for BafnaPharmaceuticals in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of BafnaPharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 114.61 and BafnaPharmaceuticals BAFNAPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the BafnaPharmaceuticals BAFNAPH stock. Volume based technical analysis of BafnaPharmaceuticals BAFNAPH stock is negative.

BafnaPharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Bafna Pharmaceuticals BAFNAPH

DMA (daily moving average) of Bafna Pharmaceuticals BAFNAPH

EMA (exponential moving average) of Bafna Pharmaceuticals BAFNAPH

SMA (simple moving average) of Bafna Pharmaceuticals BAFNAPH

Fundamentals, profit and EPS of Bafna Pharmaceuticals BAFNAPH

EPS is 3.71 and PE is: 30.64

Last quarter profit: (September 2025 quarter) 3.12 crores (19.08%)

Debt: 32.40 in crores

Market capitalization: 318.77

EPS is 3.50 and PE is: 32.48

Last quarter profit: (June 2025 quarter) 3.39 crores (1016.22%)

Debt: 28.20 in crores

Market capitalization: 245.81

Videos related to: BafnaPharmaceuticals BAFNAPH full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI